[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591732":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":56,"collaborators":10,"id":58,"slug":10,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":76,"overallStatus":48,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CBB",null,"Hypofractionated breast radiotherapy following partial mastectomy in patients with early breast cancer or ductal breast carcinoma in situ",[13],"Radiation: Hypofractionated Radiation Therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"RADIATION","Hypofractionated Radiation Therapy","Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost",[9],[21],"Hypofractionated breast radiotherapy with concomitant boost",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Yen-Ting Liu","CONTACT","88697255451","nickliucool@ntuh.gov.tw",[29,46],{"facility":5,"status":30,"city":31,"state":32,"zip":33,"country":32,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"NOT_YET_RECRUITING","Taipei","Taiwan","100",{"type":35,"coordinates":36},"Point",[37,38],121.52639,25.05306,{"lat":38,"lon":37},[41,43],{"name":24,"role":25,"phone":42,"phoneExt":10,"email":27},"886972655451",{"name":44,"role":45,"phone":10,"phoneExt":10,"email":10},"Sung-Hsin Kuo","PRINCIPAL_INVESTIGATOR",{"facility":47,"status":48,"city":31,"state":10,"zip":49,"country":32,"cosmosGeoPoint":50,"geoPoint":52,"contacts":53},"National Taiwan University Hospital Yunlin Branch","RECRUITING","632",{"type":35,"coordinates":51},[37,38],{"lat":38,"lon":37},[54,55],{"name":24,"role":25,"phone":42,"phoneExt":10,"email":27},{"name":24,"role":45,"phone":10,"phoneExt":10,"email":10},{"type":57,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100591732",false,"NCT06984250","Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer","Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer","HFCBB","Inclusion Criteria:\n\n* Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).\n* Patients undergoing breast-conserving surgery\n* Age ≥ 20 years\n* Karnofsky Performance Status (KPS) ≥70%\n* Life expectancy ≥ 5 years\n* Adequate renal and hepatic function\n\nExclusion Criteria:\n\n* Pregnant patients\n* Patients requiring re-irradiation of the thoracic region","FEMALE","20 Years","85 Years",{"count":69,"type":70},315,"ESTIMATED","OBSERVATIONAL","Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy",[74,75],"Early Breast Cancer","Ductal Breast Carcinoma In Situ",[77,78,79,80,81],"breast cancer","concomitant boost","tumor bed","Intensity-modulated radiation therapy","hypofractionated breast radiotherapy","2025-05-19",{"date":84,"type":85},"2025-05-22","ACTUAL",{"date":87,"type":85},"2025-02-06",{"date":89,"type":70},"2030-02-28",{"name":5,"class":6},2]